In February, Facet will be launching a Strategic Commercialization Services group that helps organizations understand and build health economics, market access, product launch, and reimbursement planning into their product development.  Our commercialization experts will help Sponsors select the ideal indications for their products, design the right clinical trials with endpoints that will support ideal, competitive labeling claims, and obtain optimal reimbursement after FDA approval.  Not planning to take your product all the way to FDA approval?  Strategic commercialization services can still help the company that is planning an early exit.  Working with the end in mind will add value to your asset and give you an edge when looking to divest!  Talk to Facet today about the benefits of commercialization support during investigational product development!